Charles River Laboratories International Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Charles River Laboratories International Inc's ROI in the third quarter of 2026?
Charles River Laboratories International inc achieved a return on average invested assets (ROI) of 0.64 % in its third quarter of 2026, which is below Charles River Laboratories International Inc's average return on investment, which stands at 4.25%.

ROI has improved compared to -3.63% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 213 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 2687 to 2761.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 26 2026) III. Quarter	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 27 2025) IV. Quarter	(Sep 27 2025) III. Quarter
Y / Y Investment Change TTM	-3.44 %	-3.74 %	-3.34 %	-4.97 %	-5.78 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	6,362	6,397	6,831	6,187	6,630
Return On Investment (TTM)	0.64 %	-3.63 %	-2.77 %	-2.16 %	-1.19 %
CRL's Overall Ranking	# 2761	# 2687	# 2462	# 1970	#
Seq. Investment Change TTM	-1.03 %	-1.33 %	0.19 %	-1.3 %	-1.34 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	41	-236	-183	-142	-80

CRL Company Profile >> Back to CRL Roi Comparisons >> See Annual CRL Return On Investment

Return On Investment CRL's Ranking
Within:	No.
Industry	# 12
Sector	# 214
Overall	# 2761

Return On Investment Statistics
High	Average	Low
9.11 %	4.25 %	-19.16 %
(Mar 26 2016)		(Jun 25 2011)

Financial Statements
Charles River Laboratories International Inc's III. Quarter Investments	$ 6,362 Millions	CRL's Balance sheet
Charles River Laboratories International Inc's III. Quarter Income	$ 333 Millions	Quarterly CRL's Income Statement
CRL's Income by Division		See CRL's Income by Division

CRL Annual Return On Investment	(Dec 27 2025) 2025	(Dec 28 2024) 2024	(Dec 30 2023) 2023	(Dec 31 2022) 2022	(Dec 25 2021) 2021
Total Investments in Millions	6,015	6,534	7,140	6,511	5,991
Y / Y Investment Growth	-7.94 %	-8.48 %	9.66 %	8.68 %	28.81 %
Net Income in Millions	-142	25	480	493	399
Y / Y Net Income Growth	-	-94.74 %	-2.48 %	23.51 %	9.18 %
Annual Return On Investment	-2.36 %	0.39 %	6.73 %	7.57 %	6.66 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CRL's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CRL's Competitors
Subscribers only: Roi for Charles River Laboratories International Inc's Suppliers
Subscribers only: Return On Investment for CRL's Customers

Other Ratios
CRL's Roa	CRL's Inventory Turnover Ratio	CRL's Growth Rates	CRL's Dividend Statistics
	CRL's Profitability Ratios	CRL's Asset Turnover Ratio	CRL's Dividend Growth
CRL's Roe	CRL's Valuation Ratios	CRL's Financial Strength Ratios	CRL's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 26 2026, within Healthcare Sector	ROI
Icu Medical Inc	1.74 %
Biogen Inc	1.26 %
Community Health Systems Inc	1.03 %
Integra Lifesciences Holdings Corp	0.31 %

Date modified: 2026-11-05T14:33:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.